A detailed history of Barclays PLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Barclays PLC holds 255,185 shares of WST stock, worth $80.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
255,185
Previous 171,475 48.82%
Holding current value
$80.3 Million
Previous $56.5 Million 35.61%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$277.16 - $333.3 $23.2 Million - $27.9 Million
83,710 Added 48.82%
255,185 $76.6 Million
Q2 2024

Aug 14, 2024

BUY
$314.68 - $395.94 $6.55 Million - $8.24 Million
20,815 Added 13.82%
171,475 $56.5 Million
Q1 2024

May 15, 2024

SELL
$338.27 - $413.0 $8.64 Million - $10.6 Million
-25,556 Reduced 14.5%
150,660 $59.6 Million
Q4 2023

Feb 15, 2024

BUY
$318.29 - $392.21 $5.8 Million - $7.15 Million
18,220 Added 11.53%
176,216 $62 Million
Q3 2023

Nov 07, 2023

BUY
$354.9 - $412.41 $9.68 Million - $11.2 Million
27,264 Added 20.85%
157,996 $59.3 Million
Q2 2023

Aug 03, 2023

BUY
$334.63 - $382.47 $20.1 Million - $23 Million
60,041 Added 84.93%
130,732 $50 Million
Q1 2023

May 04, 2023

SELL
$232.5 - $346.47 $5.76 Million - $8.58 Million
-24,767 Reduced 25.95%
70,691 $24.5 Million
Q4 2022

Feb 13, 2023

BUY
$209.34 - $261.61 $3.5 Million - $4.37 Million
16,704 Added 21.21%
95,458 $22.5 Million
Q3 2022

Nov 03, 2022

BUY
$246.08 - $343.65 $169,549 - $236,774
689 Added 0.88%
78,754 $19.4 Million
Q2 2022

Aug 12, 2022

SELL
$280.61 - $420.45 $19.8 Million - $29.7 Million
-70,684 Reduced 47.52%
78,065 $23.6 Million
Q1 2022

May 16, 2022

BUY
$357.49 - $445.92 $2.71 Million - $3.38 Million
7,575 Added 5.37%
148,749 $61.1 Million
Q4 2021

Feb 14, 2022

BUY
$402.25 - $471.34 $10.3 Million - $12.1 Million
25,701 Added 22.26%
141,174 $66.2 Million
Q3 2021

Nov 09, 2021

SELL
$363.01 - $468.47 $237,408 - $306,379
-654 Reduced 0.56%
115,473 $49 Million
Q2 2021

Aug 13, 2021

BUY
$284.77 - $363.2 $5.44 Million - $6.94 Million
19,099 Added 19.68%
116,127 $41.7 Million
Q1 2021

May 13, 2021

BUY
$257.29 - $307.53 $7.48 Million - $8.94 Million
29,082 Added 42.8%
97,028 $27.3 Million
Q4 2020

Feb 11, 2021

BUY
$261.16 - $301.66 $1.75 Million - $2.02 Million
6,707 Added 10.95%
67,946 $19.2 Million
Q3 2020

Nov 12, 2020

BUY
$224.99 - $288.02 $1.75 Million - $2.24 Million
7,762 Added 14.51%
61,239 $16.8 Million
Q2 2020

Aug 12, 2020

BUY
$149.8 - $227.17 $2.02 Million - $3.07 Million
13,497 Added 33.76%
53,477 $12.2 Million
Q1 2020

May 13, 2020

SELL
$128.96 - $174.76 $5.51 Million - $7.46 Million
-42,691 Reduced 51.64%
39,980 $6.09 Million
Q4 2019

Feb 10, 2020

SELL
$137.6 - $151.21 $2.43 Million - $2.67 Million
-17,681 Reduced 17.62%
82,671 $12.4 Million
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $8.82 Million - $10.9 Million
72,629 Added 261.98%
100,352 $14.2 Million
Q2 2019

Aug 14, 2019

SELL
$111.27 - $125.15 $1.23 Million - $1.38 Million
-11,026 Reduced 28.45%
27,723 $3.47 Million
Q1 2019

May 15, 2019

BUY
$94.53 - $110.2 $1.84 Million - $2.15 Million
19,498 Added 101.28%
38,749 $4.27 Million
Q4 2018

Feb 14, 2019

SELL
$93.0 - $123.98 $613,056 - $817,276
-6,592 Reduced 25.51%
19,251 $1.89 Million
Q3 2018

Nov 14, 2018

BUY
$98.01 - $123.47 $1.99 Million - $2.5 Million
20,284 Added 364.89%
25,843 $3.19 Million
Q2 2018

Aug 14, 2018

SELL
$83.32 - $101.88 $2.08 Million - $2.54 Million
-24,957 Reduced 81.78%
5,559 $553,000
Q1 2018

May 15, 2018

BUY
$85.56 - $102.4 $2.37 Million - $2.84 Million
27,709 Added 987.14%
30,516 $2.7 Million
Q4 2017

Feb 14, 2018

BUY
$91.65 - $101.65 $170,560 - $189,170
1,861 Added 196.72%
2,807 $277,000
Q3 2017

Nov 14, 2017

BUY
$84.54 - $96.75 $79,974 - $91,525
946
946 $92,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.